Point of Care Glucose Testing Market Size to Surpass $9.85 Billion by 2034 Driven by Rising Diabetes Monitoring Demand - SRI

London, UK - June 2026 | Strategic Revenue Insights Inc. –The Point Of Care Glucose Testing Market was valued at $5.14 billion in 2025 and is projected to reach $9.85 billion by 2034, growing at a CAGR of 7.5% during the forecast period 2026 to 2034. This market is expanding rapidly as global diabetes prevalence continues to rise and healthcare systems prioritize faster, decentralized diagnostic capabilities. Point of care glucose testing enables immediate blood glucose measurement without laboratory infrastructure, making it essential across hospitals, clinics, homecare settings, and emergency departments worldwide.

The integration of connected device technologies and AI-assisted monitoring platforms is transforming this market from a simple diagnostic tool segment into a comprehensive digital diabetes management ecosystem.

The global diabetes epidemic is the most powerful structural driver for the point of care glucose testing market. The International Diabetes Federation estimates that hundreds of millions of people worldwide are living with diabetes, with millions more undiagnosed. This massive and growing patient population requires frequent, reliable blood glucose monitoring as a core component of disease management. The shift toward proactive and preventive diabetes care is further increasing testing frequency per patient, driving sustained volume growth across all product categories within this market.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Point of Care Glucose Testing:

https://www.strategicrevenueinsights.com/industry/point-of-care-glucose-testing-market

Healthcare systems worldwide are actively expanding point of care testing infrastructure to reduce dependency on centralized laboratory diagnostics and accelerate clinical decision-making. In critical care, emergency, and outpatient settings, the ability to obtain glucose readings within seconds rather than waiting for laboratory turnaround times translates directly into improved patient outcomes. The expansion of homecare-based glucose monitoring is also accelerating as aging populations and health system cost pressures push chronic disease management increasingly toward patient self-management outside clinical environments.

The convergence of continuous glucose monitoring technology, smartphone connectivity, and AI-driven analytics is redefining what point of care glucose testing can deliver. Abbott's FreeStyle Libre system and Dexcom's continuous glucose monitoring platforms exemplify how real-time, wearable biosensor technology is replacing traditional finger-prick glucometry for millions of patients globally. These connected devices transmit continuous glucose data streams to mobile applications, enabling both patient self-management and remote clinical oversight. Machine learning algorithms applied to continuous glucose data are enabling predictive alerts for hypoglycemic and hyperglycemic events before they become clinically dangerous.

Browse the associated report:

https://www.strategicrevenueinsights.com/pt/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/fr/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/it/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/da/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/es/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/kr/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/ja/industry/point-of-care-glucose-testing-market

https://www.strategicrevenueinsights.com/pt/industry/point-of-care-glucose-testing-market

The product type segment covers glucometers, test strips, lancets, and continuous POCT kits. Glucometers remain the largest volume product category due to their established global installed base and low per-test cost. Test strips are the highest-frequency consumable purchase, generating recurring revenue that makes them a critical commercial segment for manufacturers. Continuous POCT kits represent the fastest-growing product category, driven by clinical evidence supporting improved glycemic control outcomes and growing patient preference for painless, real-time monitoring over periodic finger-stick testing.

The technology segment includes electrochemical biosensors, photometric testing, connected devices, and others. Electrochemical biosensors dominate the technology landscape due to their high accuracy, miniaturization capability, and compatibility with both standard glucometers and advanced continuous monitoring sensors. Connected devices are the fastest-growing technology segment, integrating Bluetooth, cloud data storage, and interoperability with electronic health record systems. Non-invasive glucose monitoring technologies, while still in development stages, represent a significant future opportunity within the others category.

By application, the market spans diabetes monitoring, critical care glucose testing, emergency care, and outpatient care. Diabetes monitoring is the largest application segment by significant margin, reflecting the sheer volume of patients requiring regular glucose assessment. Critical care glucose testing is a high-value application segment where clinical accuracy under physiologically extreme conditions is paramount, supporting premium pricing for specialized hospital-grade devices. Emergency care and outpatient care segments are growing consistently as healthcare providers expand rapid diagnostic capabilities across more care settings.

Regulatory complexity is the most significant systemic challenge in the point of care glucose testing market. Approval pathways for new glucose monitoring devices require extensive clinical validation studies and vary substantially across the United States FDA, European CE marking framework, and regulatory bodies in key Asian markets. The high cost of continuous glucose monitoring systems remains a meaningful adoption barrier in price-sensitive markets and among uninsured patient populations globally. Competition from laboratory-based glucose testing methods also limits point of care adoption in settings where centralized diagnostic infrastructure is well-established.

Related Report:

Lawn And Garden Consumables Market – https://www.strategicrevenueinsights.com/industry/lawn-and-garden-consumables-market

Special Boiling Point Solvents Market – https://www.strategicrevenueinsights.com/industry/special-boiling-point-solvents-market

Events Management Platform Market – https://www.strategicrevenueinsights.com/industry/events-management-platform-market

Energy Based Devices Market – https://www.strategicrevenueinsights.com/industry/energy-based-devices-market

Blower Market – https://www.strategicrevenueinsights.com/industry/blower-market

The United States holds the largest national market share, growing at a CAGR of 6%, underpinned by high diabetes prevalence, favorable reimbursement frameworks for continuous glucose monitoring, and the headquarters presence of leading manufacturers including Abbott, Dexcom, and Medtronic. China is growing at a CAGR of 10%, driven by a rapidly expanding diabetic population and government investment in healthcare infrastructure modernization. India is the fastest-growing major market at a CAGR of 12%, supported by surging diabetes incidence and government-led initiatives to improve rural healthcare access and telemedicine adoption. Germany, growing at a 5% CAGR, benefits from a mature healthcare system and strong clinical adoption of continuous monitoring technologies. Brazil is expanding at an 8% CAGR, reflecting growing diabetes awareness and improving healthcare infrastructure across urban centers.

Key companies in the Point Of Care Glucose Testing Market include Abbott, Roche, Ascensia Diabetes Care, LifeScan, Nova Biomedical, Siemens Healthineers, Arkray, Dexcom, Medtronic, and Acon Laboratories. Abbott leads through its FreeStyle Libre franchise, which has achieved global commercial scale across both prescription and over-the-counter channels. Roche maintains strong institutional market share through its Accu-Chek product line, while Dexcom and Medtronic lead the continuous monitoring segment through clinical differentiation and strong payer coverage relationships.

The Point Of Care Glucose Testing Market is positioned for sustained double-digit growth opportunities through 2034. Expanding global diabetes burden, accelerating continuous monitoring adoption, and the deepening integration of AI-powered glucose management platforms will drive consistent demand across all regions and care settings. Companies investing in non-invasive monitoring technology, interoperable digital health platforms, and emerging market distribution expansion are expected to capture the strongest long-term competitive positions in this critical healthcare market.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.

Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.

Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44 7877403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

State: London

Country: United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

For partnership inquiries, custom research requests, or detailed market analysis consultations, we invite you to connect with our team of experts who are committed to delivering strategic intelligence that transforms business outcomes.